Millennium Management’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10,990
| Closed | -$33.7K | – | 4542 |
|
|
2024
Q1 | $33.7K | Sell |
10,990
-6,283
| -36% | -$19.3K | ﹤0.01% | 3935 |
|
|
2023
Q4 | $40.2K | Buy |
+17,273
| New | +$40.2K | ﹤0.01% | 3830 |
|
|
2023
Q2 | – | Sell |
-27,312
| Closed | -$84K | – | 4803 |
|
|
2023
Q1 | $84K | Buy |
27,312
+200
| +0.7% | +$615 | ﹤0.01% | 4101 |
|
|
2022
Q4 | $73K | Buy |
27,112
+16,072
| +146% | +$43.3K | ﹤0.01% | 4377 |
|
|
2022
Q3 | $44K | Buy |
11,040
+1,906
| +21% | +$7.6K | ﹤0.01% | 4868 |
|
|
2022
Q2 | $64K | Sell |
9,134
-10,533
| -54% | -$73.8K | ﹤0.01% | 4789 |
|
|
2022
Q1 | $230K | Sell |
19,667
-4,304
| -18% | -$50.3K | ﹤0.01% | 4592 |
|
|
2021
Q4 | $440K | Sell |
23,971
-53
| -0.2% | -$973 | ﹤0.01% | 4113 |
|
|
2021
Q3 | $601K | Sell |
24,024
-13,710
| -36% | -$343K | ﹤0.01% | 4044 |
|
|
2021
Q2 | $2.38M | Buy |
37,734
+36,290
| +2,513% | +$2.29M | ﹤0.01% | 2983 |
|
|
2021
Q1 | $178K | Buy |
+1,444
| New | +$178K | ﹤0.01% | 4184 |
|
|
2020
Q4 | – | Sell |
-584
| Closed | -$70 | – | 4422 |
|
|
2020
Q3 | $70 | Sell |
584
-18,491
| -97% | -$2.22K | ﹤0.01% | 3451 |
|
|
2020
Q2 | $2.38M | Buy |
+19,075
| New | +$2.38M | ﹤0.01% | 1907 |
|
|
2018
Q3 | – | Sell |
-2,973
| Closed | -$1.74M | – | 3803 |
|
|
2018
Q2 | $1.74M | Buy |
+2,973
| New | +$1.74M | ﹤0.01% | 2209 |
|